1
|
Hartl DM, Breuskin I, Brasnu D. TIRO (Thyroid International Recommendations Online) now available in French. Eur Ann Otorhinolaryngol Head Neck Dis 2024; 141:117. [PMID: 37648567 DOI: 10.1016/j.anorl.2023.08.004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 09/01/2023]
Affiliation(s)
- D M Hartl
- Département d'anesthésie, chirurgie et interventionnel, service de cancérologie cervico-faciale, Gustave-Roussy, 114, rue Édouard-Vaillant, 94805 Villejuif cedex, France.
| | - I Breuskin
- Département d'anesthésie, chirurgie et interventionnel, service de cancérologie cervico-faciale, Gustave-Roussy, 114, rue Édouard-Vaillant, 94805 Villejuif cedex, France
| | - D Brasnu
- Service d'ORL et de chirurgie cervico-faciale, hôpital fondation A. de Rothschild, 25, rue Manin, 75019 Paris, France
| |
Collapse
|
2
|
Dupuch G, Mailly M, Guillaume J, Daval M, Ayache D, Brasnu D. Incidence and risk factors for secondary extralaryngeal dystonia in patients with laryngeal dystonia. Am J Otolaryngol 2024; 45:104090. [PMID: 37865985 DOI: 10.1016/j.amjoto.2023.104090] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/08/2023] [Accepted: 10/10/2023] [Indexed: 10/24/2023]
Abstract
BACKGROUND AND OBJECTIVES Laryngeal dystonia (LD) is a focal dystonia affecting adductor and/or abductor muscles of the larynx. It can be isolated or may spread to extra laryngeal muscles. The aim of this study was to report the characteristics of LD over time in a large single-center study with a long follow-up. METHODS Retrospective review of patients with LD referred to our institution between 1991 and 2021. Demographic data, time to diagnosis, type of LD, follow-up and spread of dystonia [SD] were recorded. Risk factors for spread of dystonia during follow-up were analyzed. RESULTS Over the 30-year period, 516 patients (77.3 % female, median age 50 years, range 5-87 years) were analyzed. Three hundred and fifteen patients (61 %) had adduction laryngeal dystonia, 136 patients (26.4 %) had abduction laryngeal dystonia, 46 patients (8.9 %) had adductor respiratory laryngeal dystonia, 12 patients (2.3 %) had mixed laryngeal dystonia, and seven patients (1.4 %) had singer's laryngeal dystonia. A previous history of dystonia was found in 47 patients (9.1 %). A laryngeal tremor was found in 68 patients (13.2 %). Since the onset of symptoms, LD was diagnosed after a median of 3 years (IQR: 1.0, 7.0). SD occurred in 55 patients (10.7 %) after a median time of 4 year (IQR: 1.5, 13.0). Patients with mixed laryngeal dystonia had higher probability of SD (p = 0.018). DISCUSSION This study reports a large European study of LD, with a long follow-up. SD occurred in 10.5 % of patients. Patients with mixed laryngeal dystonia had a higher probability of SD. A close follow-up may be recommended for patients with mixed laryngeal dystonia.
Collapse
Affiliation(s)
- Guillaume Dupuch
- Department of Otolaryngology Head &Neck Surgery, Rothschild Hospital Foundation, Paris, France.
| | - Marie Mailly
- Department of Otolaryngology Head &Neck Surgery, Rothschild Hospital Foundation, Paris, France
| | - Jessica Guillaume
- Department of Clinical Research, Rothschild Hospital Foundation, Paris, France
| | - Mary Daval
- Department of Otolaryngology Head &Neck Surgery, Rothschild Hospital Foundation, Paris, France
| | - Denis Ayache
- Department of Otolaryngology Head &Neck Surgery, Rothschild Hospital Foundation, Paris, France
| | - Daniel Brasnu
- Department of Otolaryngology Head &Neck Surgery, Rothschild Hospital Foundation, Paris, France
| |
Collapse
|
3
|
Hans S, Crevier-Buchman L, Circiu M, Idrissi YC, Distinguin L, de Mones E, Brasnu D, Lechien JR. Oncological and Surgical Outcomes of Patients Treated by Transoral CO 2 Laser Cordectomy for Early-Stage Glottic Squamous Cell Carcinoma: A Retrospective Chart Review. Ear Nose Throat J 2020; 100:33S-37S. [PMID: 32204623 DOI: 10.1177/0145561320911486] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/03/2023] Open
Abstract
OBJECTIVE To investigate the feasibility and the outcomes of transoral laser CO2 microsurgery (TLM) for resection of early-stage squamous cell carcinoma (SCC) of the vocal folds through several additional surgical procedures and tips improving the glottic exposure. METHODS Retrospective chart review of patients treated by TLM cordectomy in a single European University Hospital for early-stage vocal fold SCCs (Tis, T1a, T1b, and T2). The following TLM outcomes were studied regarding the tumor size (Tis and T1a vs T1b and T2) and the margin status (negative vs positive/suspicious): patient position; type of laryngoscope; requirement to external counter pressure; resection of supraglottic structures (eg, ventricular band, epiglottic petiole, and suprahyoid epiglottis); pre- and postoperative complications; overall survival; disease-specific survival (DSS); and disease-free survival (DFS). RESULTS A total of 148 patients were included. The TLM was realized in 95.3% of cases. External counter pressure, partial, or total vestibulectomy were necessary in 65.9%, 57.4%, and 4.2% of cases, respectively. A resection of the epiglottic petiole was required in 24.8% of cases. The realization of both epiglottis petiole resection and vestibulectomies were significantly higher in patients with T2 and T1b SCCs compared to those with T1a and Tis SCCs (P = .01). Different procedure tips were described for improving the laryngeal exposition. The 5-year laryngeal preservation rate, DSS, and DFS were significantly better in patients without SCC involvement of the anterior commissure, and did not vary according to the margin status. The laryngeal exposure difficulties did not impact the margin status. CONCLUSION The exposure of glottis is possible in 95% of cases of early-stage vocal cord SCC but requires the use of several additional surgical procedures, especially for anterior commissure SCCs. The SCC involvement of the vocal fold anterior commissure is associated with lower DSS, DFS, and laryngeal preservation rate.
Collapse
Affiliation(s)
- Stéphane Hans
- Department of Otolaryngology-Head and Neck Surgery, 37918Foch Hospital, School of Medicine, UFR Simone Veil, Université Versailles Saint-Quentin-en-Yvelines (Paris Saclay University), Paris, France
| | - Lise Crevier-Buchman
- Department of Otolaryngology-Head and Neck Surgery, 37918Foch Hospital, School of Medicine, UFR Simone Veil, Université Versailles Saint-Quentin-en-Yvelines (Paris Saclay University), Paris, France
| | - Marta Circiu
- Department of Otolaryngology-Head and Neck Surgery, 37918Foch Hospital, School of Medicine, UFR Simone Veil, Université Versailles Saint-Quentin-en-Yvelines (Paris Saclay University), Paris, France
| | - Younes Chekkoury Idrissi
- Department of Otolaryngology-Head and Neck Surgery, 37918Foch Hospital, School of Medicine, UFR Simone Veil, Université Versailles Saint-Quentin-en-Yvelines (Paris Saclay University), Paris, France
| | - Léa Distinguin
- Department of Otolaryngology-Head and Neck Surgery, 37918Foch Hospital, School of Medicine, UFR Simone Veil, Université Versailles Saint-Quentin-en-Yvelines (Paris Saclay University), Paris, France
| | - Erwan de Mones
- Department of Otolaryngology-Head and Neck Surgery, Bordeaux University, France
| | - Daniel Brasnu
- Department of Otolaryngology-Head and Neck Surgery, 55659Fondation A. Rothschild, Paris, France
| | - Jérôme R Lechien
- Department of Otolaryngology-Head and Neck Surgery, 37918Foch Hospital, School of Medicine, UFR Simone Veil, Université Versailles Saint-Quentin-en-Yvelines (Paris Saclay University), Paris, France.,Laryngology Study Group of Young Otolaryngologists of International Federation of Otorhinolaryngological Societies (YO-IFOS), Paris, France
| |
Collapse
|
4
|
Hamzany Y, Crevier-Buchman L, Lechien JR, Bachar G, Brasnu D, Hans S. Multidimensional Voice Quality Evaluation After Transoral CO 2 Laser Cordectomy: A Prospective Study. Ear Nose Throat J 2020; 100:27S-32S. [PMID: 32067482 DOI: 10.1177/0145561320906328] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022] Open
Abstract
OBJECTIVE To investigate voice quality changes of patients treated by transoral laser cordectomy (TLC) for early glottic cancer according to the type of cordectomies. METHODS A total of 164 consecutive male patients with an early glottic cancer were prospectively recruited from the Department of Otolaryngology-Head and Neck Surgery of the Georges Pompidou European Hospital. Depending on the tumor characteristics, patients benefited from type I to VI CO2 cordectomy regarding the European Laryngological Society classification. The following voice quality outcomes were pre- to postoperatively assessed: voice handicap index (VHI), perceptual grade of dysphonia, roughness, breathiness, maximum phonation time, and acoustic parameters. RESULTS Fifty-five patients with Tis, T1, or T2 vocal fold cancer completed the study (mean age: 61.7 years). Of these patients, 34 and 21 composed group 1 (types I-III TLC) and group 2 (types IV-VI TLC), respectively. Voice handicap index, grade of dysphonia, and breathiness significantly improved from pre- to 3- and 6-month posttreatment in group 1. In group 2, only VHI significantly improved from pre- to 3- and 6-month posttreatment. Acoustic and aerodynamic measurements did not change throughout the postoperative course. Patients with types I to III TLC exhibited better postoperative voice outcomes compared to those treated by types IV to VI TLC. CONCLUSION Irrespective to the types of TLC, the subjective voice quality of patients treated by CO2 laser cordectomy for early glottic cancer significantly improved from pre- to 3- and 6-month posttreatment. The usefulness of aerodynamic and acoustic measurements as postoperative outcomes of voice quality changes remain controversial and require future studies considering multidimensional assessment of voice.
Collapse
Affiliation(s)
- Yaniv Hamzany
- Department of Otolaryngology-Head and Neck Surgery, 36632Rabin Medical Center, Petach Tikva and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
| | - Lise Crevier-Buchman
- Department of Otolaryngology-Head and Neck Surgery, 37918Foch Hospital, School of Medicine, UFR Simone Veil, Université Versailles Saint-Quentin-en-Yvelines (Paris Saclay University), Paris, France
| | - Jérôme R Lechien
- Department of Otolaryngology-Head and Neck Surgery, 37918Foch Hospital, School of Medicine, UFR Simone Veil, Université Versailles Saint-Quentin-en-Yvelines (Paris Saclay University), Paris, France.,Laryngology Study Group of Young Otolaryngologists of International Federation of Otorhinolaryngological Societies (YO-IFOS), Paris, France
| | - Gideon Bachar
- Department of Otolaryngology-Head and Neck Surgery, 36632Rabin Medical Center, Petach Tikva and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
| | - Daniel Brasnu
- Department of Otolaryngology-Head Neck Surgery, 55659Fondation A. Rothschild, Paris Descartes University (Sorbonne), Paris, France
| | - Stéphane Hans
- Department of Otolaryngology-Head and Neck Surgery, 37918Foch Hospital, School of Medicine, UFR Simone Veil, Université Versailles Saint-Quentin-en-Yvelines (Paris Saclay University), Paris, France
| |
Collapse
|
5
|
Rebours C, Brasnu D, Le Garrec S, Ayache D, Mailly M. Laryngeal Electromyography and Botulinum Toxin Injection in Exercise-Induced Laryngeal Obstruction. Mov Disord Clin Pract 2019; 6:708-710. [PMID: 31745483 DOI: 10.1002/mdc3.12836] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/28/2019] [Revised: 07/19/2019] [Accepted: 08/20/2019] [Indexed: 01/16/2023] Open
Affiliation(s)
- Céleste Rebours
- Department of Otolaryngology, Head and Neck Surgery Fondation A. de Rothschild Paris France
| | - Daniel Brasnu
- Department of Otolaryngology, Head and Neck Surgery Fondation A. de Rothschild Paris France
| | | | - Denis Ayache
- Department of Otolaryngology, Head and Neck Surgery Fondation A. de Rothschild Paris France
| | - Marie Mailly
- Department of Otolaryngology, Head and Neck Surgery Fondation A. de Rothschild Paris France
| |
Collapse
|
6
|
Mailly M, Benzakin S, Chauvin A, Brasnu D, Ayache D. [Radiation-induced head and neck pain: Management with botulinum toxin a injections]. Cancer Radiother 2019; 23:312-315. [PMID: 31147172 DOI: 10.1016/j.canrad.2019.02.001] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/18/2018] [Revised: 02/05/2019] [Accepted: 02/07/2019] [Indexed: 11/30/2022]
Abstract
PURPOSE To report the results of Botulinum Toxin A (BTA) for radiation-induced head and neck pain. MATERIALS AND METHODS This single-center retrospective study included all the patients treated at our institution with botulinum toxin A injections for radiation-induced head and neck pain between 2006 and 2017. Pain was evaluated by each patient on a visual analogue scale (VAS) (between 0 and 10) before, and 1 month after the injection. RESULTS Sixteen patients were included in this series. The mean value of the pain was 8.5 before and 8 after the first injection. The difference was statistically significant (p<0.01). Major response occurred in 15 patients (VAS≤3 after BTA) and complete response in 11 patients (VAS=0 after BTA). CONCLUSION Botulinum toxin is an effective treatment for radiation-induced head and neck pain.
Collapse
Affiliation(s)
- M Mailly
- Service d'ORL et chirurgie cervico-faciale, fondation Adolphe de Rothschild, 29, rue Manin, 75019 Paris, France.
| | - S Benzakin
- Service d'ORL et chirurgie cervico-faciale, fondation Adolphe de Rothschild, 29, rue Manin, 75019 Paris, France
| | - A Chauvin
- Service d'accueil des urgences, hôpital Lariboisière, Assistance publique-Hôpitaux de Paris, 2, rue Ambroise-Paré, 75010 Paris, France; Faculté de médecine, université Diderot, Paris, France
| | - D Brasnu
- Service d'ORL et chirurgie cervico-faciale, fondation Adolphe de Rothschild, 29, rue Manin, 75019 Paris, France; Faculté de médecine René-Descartes, université Sorbonne Paris Cité, Paris, France
| | - D Ayache
- Service d'ORL et chirurgie cervico-faciale, fondation Adolphe de Rothschild, 29, rue Manin, 75019 Paris, France
| |
Collapse
|
7
|
Slaim L, Cohen M, Klap P, Vidailhet M, Perrin A, Brasnu D, Ayache D, Mailly M. Oromandibular Dystonia: Demographics and Clinical Data from 240 Patients. J Mov Disord 2018; 11:78-81. [PMID: 29860784 PMCID: PMC5990905 DOI: 10.14802/jmd.17065] [Citation(s) in RCA: 23] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/07/2017] [Revised: 01/18/2018] [Accepted: 04/04/2018] [Indexed: 11/24/2022] Open
Abstract
Objective
To report demographic data from a large cohort of patients with oromandibular dystonia (OMD). Methods
This is a retrospective review of patients with OMD referred to our institution between 1989 and 2015. Demographic (age of onset, gender, and familial history of dystonia) and clinical (type of OMD, associated dystonia, and etiology of dystonia) data were collected from a cohort of 240 individuals. Results
The mean age of onset of OMD was 51.6 years old, with a female predominance (2:1). A family history of dystonia was found in 6 patients (2.5%). One hundred and forty-nine patients (62.1%) had the jaw-opening type of OMD, 48 patients (20.0%) had the jaw-closing type, and 43 patients (17.9%) had a mixed form of OMD. Lingual dystonia was also present in 64 (26.7%) of these patients. Eighty-two patients (34.2%) had a focal dystonia, 131 patients (54.6%) had a segmental dystonia, and 27 patients (11.3%) had a generalized dystonia. One hundred and seventy-one patients (71.3%) had idiopathic OMD. Conclusion
OMD is a chronic and disabling focal dystonia. Our study found a prevalence of female patients, an onset in middle age and a predominantly idiopathic etiology. Unlike other studies, jaw-opening was found to be the most frequent clinical type of OMD.
Collapse
Affiliation(s)
- Linda Slaim
- Department of ENT and Head and Neck Surgery, Fondation Adolphe de Rothschild, Paris, France
| | - Myriam Cohen
- Department of ENT and Head and Neck Surgery, Fondation Adolphe de Rothschild, Paris, France
| | - Patrick Klap
- Department of ENT and Head and Neck Surgery, Fondation Adolphe de Rothschild, Paris, France
| | - Marie Vidailhet
- Department of Neurology, Hôpital de la Pitié Salpétrière, Assistance Publique-Hôpitaux de Paris, Paris, France
| | - Alain Perrin
- Department of ENT and Head and Neck Surgery, Fondation Adolphe de Rothschild, Paris, France
| | - Daniel Brasnu
- Department of ENT and Head and Neck Surgery, Fondation Adolphe de Rothschild, Paris, France.,Université Paris Descartes Sorbonne, Paris Cité, France
| | - Denis Ayache
- Department of ENT and Head and Neck Surgery, Fondation Adolphe de Rothschild, Paris, France
| | - Marie Mailly
- Department of ENT and Head and Neck Surgery, Fondation Adolphe de Rothschild, Paris, France
| |
Collapse
|
8
|
Laccourreye O, Hans S, Borzog-Grayeli A, Maulard-Durdux C, Brasnu D, Housset M. Complications of Postoperative Radiation Therapy after Partial Laryngectomy in Supraglottic Cancer: A Long-Term Evaluation. Otolaryngol Head Neck Surg 2016; 122:752-7. [PMID: 10793360 DOI: 10.1016/s0194-5998(00)70210-5] [Citation(s) in RCA: 24] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
This retrospective study, based on a series of 90 patients with invasive squamous cell carcinoma of the supraglottis, was designed to document the functional outcome and complications after postoperative radiation therapy following partial laryngeal surgery. The surgical procedure was a standard supraglottic laryngectomy in 62 patients and a supracricoid partial laryngectomy in 28 patients. All of the patients had an unremarkable postoperative course and achieved locoregional control. The average dose delivered to the remaining larynx was 51.2 Gy (range 25–71 Gy). The average dose delivered to the neck was 50.6 Gy (range 2270 Gy). The patients were treated at 180-cGy per fractions in a continuous course technique with a cobalt 60 beam. In 5 patients (5.5%) complications led to cessation of postoperative radiation therapy, and the total dose delivered to the remaining larynx and neck was less than 40 Gy. All patients were followed up for a minimum of 10 years or until death. The 5-, 10-, and 15-year actuarial survival estimates were 71.5%, 44.3%, and 36.3%, respectively. The 5-, 10-, and 15-year actuarial severe complication estimates were all 11.2%. Overall, severe complications occurred in 15 patients. Severe complications led to death in 3 patients (3.3%), permanent gastrostomy in 3 (3.3%), and permanent tracheostomy in 1 (1.1%). A severe complication never resulted in completion of total laryngectomy. In univariate analysis, the mean dose delivered to the larynx was the only variable statistically related to the incidence of a severe complication. The mean dose delivered to the larynx was statistically higher (P = 0.014) in patients who had severe complications (60 Gy) than in patients who did not (50 Gy).
Collapse
Affiliation(s)
- O Laccourreye
- Department of Otorhinolaryngology-Head and Neck Surgery, Laënnec Hospital, University Paris V, France
| | | | | | | | | | | |
Collapse
|
9
|
Kania R, Hans S, Garcia D, Brasnu D, De Mones E, Laccourreye O. Supracricoid Hemilaryngopharyngectomy in Patients with Invasive Squamous Cell Carcinoma of the Pyriform Sinus. Ann Otol Rhinol Laryngol 2016; 114:95-104. [PMID: 15757187 DOI: 10.1177/000348940511400203] [Citation(s) in RCA: 20] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
Supracricoid hemilaryngopharyngectomy (SCHLP) was performed in 147 patients over a 19-year period for previously untreated invasive squamous cell carcinoma of the pyriform sinus. With a minimum of 3 years' follow-up, the current retrospective series was designed to document the incidence, risk factors, and consequences of local recurrence following SCHLP. Before operation, 97.4% of patients had an induction chemotherapy regimen. A complete clinical response and a complete histologic regression were noted in 21.7% and 16.8% of patients, respectively. A significant statistical relationship (p = .0001) was noted between complete clinical response and complete histologic regression. Postoperative radiotherapy was used in 49.8% of patients. The overall local recurrence rate was 8.2%. The 5-year actuarial (Kaplan-Meier life-table method) local control estimate was 90.4%. As a function of T stage, the 5-year actuarial local control estimates were 96.2%, 91.1%, 92.9%, and 62.6% in patients with tumors classified as T1, T2, T3, and T4a, respectively. On univariate analysis, the overall local recurrence rate varied significantly, from 5.3% to 55.6% if the apex of the pyriform sinus was invaded (p = .02), 6.9% to 18.7% if the posterior pharyngeal wall was invaded (p = .03), and 6.3% to 60% if the margins of resection were positive (p = .02). In a stepwise regression model, positive margins of resection (odds ratio, 8.4; 95% confidence interval, 2.2 to 32.2; p = .002) and invasion of the apex of the pyriform sinus (odds ratio, 6.1; 95% confidence interval, 1.1 to 33.3; p = .04) were the variables statistically associated with an increased risk of local recurrence. Local recurrence resulted in a statistically significant increased risk of nodal recurrence (p = .005) and death (p < .004). The overall laryngeal preservation rate was 91.2%. From an oncological perspective, these results suggest that SCHLP should become a major tool in the armamentarium of the head and neck surgeon and should be integrated into future trials aimed at organ preservation in patients with invasive squamous cell carcinoma of the pyriform sinus.
Collapse
Affiliation(s)
- Romain Kania
- Department of Otorhinolaryngology-Head and Neck Surgery, Hôpital Européen Georges Pompidou, Assistance Publique des Hôpitaux de Paris, University of Paris V, Paris, France
| | | | | | | | | | | |
Collapse
|
10
|
Hoffmann C, Cornu N, Hans S, Sadoughi B, Badoual C, Brasnu D. Early glottic cancer involving the anterior commissure treated by transoral laser cordectomy. Laryngoscope 2015; 126:1817-22. [DOI: 10.1002/lary.25757] [Citation(s) in RCA: 47] [Impact Index Per Article: 5.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/25/2015] [Revised: 09/16/2015] [Accepted: 10/02/2015] [Indexed: 11/06/2022]
Affiliation(s)
| | | | | | - Babak Sadoughi
- The Sean Parker Institute for the Voice; Department of Otolaryngology-Head and Neck Surgery; Weill Cornell Medical College; New York New York U.S.A
| | - Cécile Badoual
- Department of Pathology; Hôpital Européen Georges Pompidou; Paris France
| | | |
Collapse
|
11
|
Hoffmann C, Hans S, Sadoughi B, Brasnu D. Identifying outcome predictors of transoral laser cordectomy for early glottic cancer. Head Neck 2015; 38 Suppl 1:E406-11. [DOI: 10.1002/hed.24007] [Citation(s) in RCA: 32] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 01/06/2015] [Indexed: 11/10/2022] Open
Affiliation(s)
- Caroline Hoffmann
- Department of Otolaryngology-Head and Neck Surgery; Hôpital Européen Georges Pompidou; Paris France
| | - Stéphane Hans
- Department of Otolaryngology-Head and Neck Surgery; Hôpital Européen Georges Pompidou; Paris France
| | - Babak Sadoughi
- Department of Otolaryngology-Head and Neck Surgery; Mount Sinai Beth Israel; New York NY
| | - Daniel Brasnu
- Department of Otolaryngology-Head and Neck Surgery; Hôpital Européen Georges Pompidou; Paris France
| |
Collapse
|
12
|
Legeay K, Kfoury M, Leroy P, Gervais C, Hans S, Aubaret C, Sauvajot C, Tripault L, Guillou A, Brasnu D, Oudard S, Herve C, Scotte F. Supportive Cancer Care In-Patient Unit: a Three Years Experience. Ann Oncol 2014. [DOI: 10.1093/annonc/mdu352.13] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
13
|
Kfoury M, Leroy P, Hans S, Herve C, Brasnu D, Oudard S, Sauvajot C, Aubaret C, Tripault L, Guillou A, Scotte F. In-patient supportive care unit in oncology: A 3-year assessment (2011-2013). J Clin Oncol 2014. [DOI: 10.1200/jco.2014.32.15_suppl.e20708] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Affiliation(s)
- Maria Kfoury
- Supportive Care Functionnal Unit, Medical Oncology Department, Georges Pompidou European Hospital, Paris, France
| | - Pauline Leroy
- Supportive Care Unit, Medical Oncology Department, Georges Pompidou European Hospital, Paris, France
| | - Stephane Hans
- Hôpital Européen Georges Pompidou, APHP, Paris, France
| | | | | | - Stephane Oudard
- Department of Medical Oncology, Hôpital Européen Georges Pompidou, René Descartes University, Paris, France
| | - Clarisse Sauvajot
- Supportive Care Functionnal Unit, Medical Oncology Department, Georges Pompidou European Hospital, Paris, France
| | - Christophe Aubaret
- Supportive Care Functionnal Unit, Medical Oncology Department, Georges Pompidou European Hospital, Paris, France
| | - Ludovic Tripault
- Supportive Care Functionnal Unit, Medical Oncology Department, Georges Pompidou European Hospital, Paris, France
| | - Anne Guillou
- Supportive Care Functionnal Unit, Medical Oncology Department, Georges Pompidou European Hospital, Paris, France
| | - Florian Scotte
- Supportive Care Functionnal Unit, Medical Oncology Department, Georges Pompidou European Hospital, Paris, France
| |
Collapse
|
14
|
Abstract
The growing practice of endoscopic surgery has changed the therapeutic management of selected head and neck cancers. Although a negative surgical margin in resection of neoplasm is the most important surgical principle in oncologic surgery, controversies exist regarding assessment and interpretation of the status of margin resection. The aim of this review was to summarize the literature considering the assessment and feasibility of negative margins in transoral laser microsurgery (TLM) and transoral robotic surgery (TORS). Free margin status is being approached differently in vocal cord cancer (1-2 mm) compared with other sites in the upper aerodigestive tract (2-5 mm). Exposure, orientation of the pathological specimen, and co-operation with the pathologist are crucial principles needed to be followed in transoral surgery. Piecemeal resection to better expose deep tumor involvement and biopsies taken from surgical margins surrounding site of resection can improve margin assessment. High rates of negative surgical margins can be achieved with TLM and TORS. Adjuvant treatment decision should take into consideration also the surgeon's judgment with regard to the completeness of tumor resection.
Collapse
Affiliation(s)
- Yaniv Hamzany
- Department of Otorhinolaryngology—Head and Neck Surgery, Rabin Medical Center, Petach Tikva and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel and
- To whom correspondence should be addressed. E-mail:
| | - Daniel Brasnu
- Department of Otorhinolaryngology—Head Neck Surgery, Université Paris Descartes, Sorbonne Paris Cité, Hôpital Européen Georges Pompidou, Assistance Publique—Hôpitaux de Paris, Paris, France
| | - Thomas Shpitzer
- Department of Otorhinolaryngology—Head and Neck Surgery, Rabin Medical Center, Petach Tikva and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel and
| | - Jacob Shvero
- Department of Otorhinolaryngology—Head and Neck Surgery, Rabin Medical Center, Petach Tikva and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel and
| |
Collapse
|
15
|
Cros J, Sbidian E, Hans S, Roussel H, Scotte F, Tartour E, Brasnu D, Laurent-Puig P, Bruneval P, Blons H, Badoual C. Expression and mutational status of treatment-relevant targets and key oncogenes in 123 malignant salivary gland tumours. Ann Oncol 2013; 24:2624-2629. [PMID: 23933559 DOI: 10.1093/annonc/mdt338] [Citation(s) in RCA: 62] [Impact Index Per Article: 5.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/20/2022] Open
Abstract
BACKGROUND Malignant tumours of the salivary glands (MSGT) are rare and pleomorphic entities. Patients with advanced disease may benefit from targeted therapy; however, specific targets for optimising and personalising treatments are yet to be identified. DESIGN Immunohistochemistry for C-KIT, EGFR, HER2, MUC1, phospho-mTOR, androgen/estrogens/progesterone receptors and Ki67 was carried out and evaluated in terms of progression-free and overall survival. High throughput molecular screening of key oncogenes was done in 107 patients using routine diagnostic methods and Sequenom technology. RESULTS Several therapy leads were identified, including high levels of HER2 and androgen receptors in salivary duct carcinomas, C-KIT in myoepithelial carcinomas and EGFR in mucoepidermoid carcinomas. Recurrent mutations involving downstream elements of the EGFR pathway were found in HRAS, notably in tumours with a myoepithelial component, and in other key oncogenes (KRAS/NRAS/PI3KCA/BRAF/MAP2K). On the other hand, <1% of samples had EGFR or HER2 mutations. CONCLUSION Several tumour subtypes overexpressed targets of directed therapies suggesting potential therapy leads. Genotyping results suggest activation downstream of EGFR in 18 of the 107 samples that could be associated with low efficacy of EGFR inhibitors. Other molecules, such as PI3K/MEK or mTOR inhibitors, may have anti-tumour activity in this subgroup. The high mutation rate in HRAS highlights a novel key oncogenic event in MSGT.
Collapse
Affiliation(s)
- J Cros
- Department of Pathology, G. Pompidou European Hospital APHP-Université Paris Descartes, Paris
| | - E Sbidian
- Department of Public Health, University Paris Est Créteil-EA4393, Creteil
| | - S Hans
- Departments of Head and Neck Surgery
| | - H Roussel
- Department of Pathology, G. Pompidou European Hospital APHP-Université Paris Descartes, Paris
| | - F Scotte
- Oncology, G. Pompidou European Hospital-Université Paris Descartes, Paris
| | - E Tartour
- INSERM U970 Paris-Centre de recherche Cardiovasculaire Team 10, Paris
| | - D Brasnu
- Departments of Head and Neck Surgery
| | - P Laurent-Puig
- Department of Biochemistry and Molecular Oncology, G. Pompidou European Hospital-Université Paris Descartes, Inserm Unité Mixte de Recherche-S775, Paris, France
| | - P Bruneval
- Department of Pathology, G. Pompidou European Hospital APHP-Université Paris Descartes, Paris
| | - H Blons
- Department of Biochemistry and Molecular Oncology, G. Pompidou European Hospital-Université Paris Descartes, Inserm Unité Mixte de Recherche-S775, Paris, France
| | - C Badoual
- Department of Pathology, G. Pompidou European Hospital APHP-Université Paris Descartes, Paris; INSERM U970 Paris-Centre de recherche Cardiovasculaire Team 10, Paris.
| |
Collapse
|
16
|
de Torcy T, Clouet A, Pillot-Loiseau C, Vaissière J, Brasnu D, Crevier-Buchman L. A video-fiberscopic study of laryngopharyngeal behaviour in thehuman beatbox. LOGOP PHONIATR VOCO 2013; 39:38-48. [DOI: 10.3109/14015439.2013.784801] [Citation(s) in RCA: 24] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
|
17
|
Nizard M, Sandoval F, Badoual C, Pere H, Terme M, Hans S, Benhamouda N, Granier C, Brasnu D, Tartour E. Immunotherapy of HPV-associated head and neck cancer: Critical parameters. Oncoimmunology 2013; 2:e24534. [PMID: 23894716 PMCID: PMC3716751 DOI: 10.4161/onci.24534] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/30/2013] [Accepted: 04/03/2013] [Indexed: 11/19/2022] Open
Abstract
Various arguments support the development of a vaccine targeting human papillomavirus (HPV) for the treatment of HPV-associated head and neck cancer. However, the mucosal localization of this tumor, the HPV-driven downregulation of MHC Class I molecules and various other immunosuppressive mechanisms must be carefully considered to improve the clinical efficacy of such an immunotherapeutic strategy.
Collapse
Affiliation(s)
- Mevyn Nizard
- INSERM U970 PARCC; Université Paris Descartes; Paris, France
| | | | | | | | | | | | | | | | | | | |
Collapse
|
18
|
Gorphe P, Hartl D, Primov-Fever A, Hans S, Crevier-Buchman L, Brasnu D. Endoscopic laser medial arytenoidectomy for treatment of bilateral vocal fold paralysis. Eur Arch Otorhinolaryngol 2013; 270:1701-5. [DOI: 10.1007/s00405-013-2414-3] [Citation(s) in RCA: 37] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/20/2012] [Accepted: 02/19/2013] [Indexed: 11/30/2022]
|
19
|
Brasnu D. Robot-assisted submandibular gland resection via retroauricular approaches: Does the end justify the means? Laryngoscope 2013; 123:374-5. [DOI: 10.1002/lary.23733] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/20/2012] [Accepted: 08/22/2012] [Indexed: 11/08/2022]
|
20
|
Smith RV, Schiff BA, Sarta C, Hans S, Brasnu D. Transoral robotic total laryngectomy. Laryngoscope 2013; 123:678-82. [PMID: 23299907 DOI: 10.1002/lary.23842] [Citation(s) in RCA: 57] [Impact Index Per Article: 5.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/16/2012] [Revised: 09/05/2012] [Accepted: 10/01/2012] [Indexed: 11/11/2022]
Abstract
OBJECTIVES/HYPOTHESIS Minimally invasive surgery has become the standard of care in many organ systems. Head and neck surgery has incorporated transoral surgery, either laser microsurgery or robotic resection, in the management of pharyngeal and laryngeal cancers. To date, the laryngeal procedures have taken the form of partial laryngectomy, as transoral approaches have not allowed reconstruction following total laryngectomy. We present the first series of transoral total laryngectomies. STUDY DESIGN Multinational, multi-institutional prospective consecutive case series. METHODS Case series of completed and attempted transoral robotic surgery (TORS) total laryngectomy performed under an institutional review board protocol. The procedure was developed in the cadaver laboratory and applied to selected individuals requiring total laryngectomy for recurrent laryngeal cancer or post-therapeutic organ dysfunction. RESULTS TORS total laryngectomy was successfully performed in five patients and was unsuccessful in two others. Two of the patients had postoperative fistulae, and all seven are without evidence of recurrent cancer and are swallowing orally without gastrostomy supplementation. CONCLUSIONS TORS total laryngectomy is feasible and can be taught to other surgeons. Potential benefits of this approach are present for patients undergoing salvage laryngectomy and include improved wound healing and functional results. This procedure further extends the applications of robotic head and neck surgery.
Collapse
Affiliation(s)
- Richard V Smith
- Department of Otorhinolaryngology-Head and Neck Surgery, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, New York 10467, USA.
| | | | | | | | | |
Collapse
|
21
|
Hans S, Hoffman C, Croidieu R, Vialatte de Pemille G, Crevier-Buchman L, Monfrais-Pfauwadel MC, Menard M, Brasnu D. [Evaluation of quality of life and swallowing in patients with cancer of the oropharynx treated with assisted transoral robotic surgery]. Rev Laryngol Otol Rhinol (Bord) 2013; 134:49-56. [PMID: 24494332] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/03/2023]
Abstract
OBJECTIVES To present the preliminary results of the qualiit of life and quality of swallowing in a series of 15 patien! treated with oropharyngectomy by transoral robotic-assisted (CTAR) (robot da Vinci, Intuitive Surgical ). MATERIALS AND METHODS A prospective monocentric non-randomized study of 15 patients with cancer of the oropharynx. Were analyzed: demographics, quality of life questionnaires (QLQ-C30 and H&N 35 EORTC) and quality of swallowing questionnairex (MDADI, DHI and EAT 10) with an average of 1 year after the end of the treatment. RESULTS Fifteen patients (10 males and 5 females), mean age of 65 years (47-73 years) were included. The tumours were classified as: cT1: 4; cT2: 10 cT3: 1. Five of the 15 patients received postoperative chemoradiotherapy as histo-pathological studies showed multiple metastatic cervical lymph nodes +/- capsular rupture. For the analysis of the quality of life and quality of swallowing, the patients were divided into two groups. Group A included patients who underwent CTARs and group B, patients operated by CTAR with adjuvant chemoradiotherapy. At 12 months of the procedure, all patients had a deglutition considered as normal without feeding tube nor tracheostomy. With the three scales used, the quality of swallowing was satisfactory for all patients. It was better for patients in group A than for patients in group B. In terms of quality of life, the EORTC QLQ-C30 scale showed our patients had a high rate of satisfaction scale in "health and overall quality of life". For the EORTC H&N35 questionnaire, mean scores for "specific symptoms" were also low except for the following three items "dry mouths", "sticky saliva" and "sexuality problem". The first two items were statistically more frequent (p = 0.02 and p = 0.001) in group B patients. CONCLUSION After transoral robotic-assisted oropharyngectomy, patients have a good quality of life and swallowing. Postoperative chemoradio-therapy compromises the quality of swallowing. Multicentric studies are required to confirm these preliminary results.
Collapse
Affiliation(s)
- S Hans
- Hôpital Européen Georges Pompidou, Department of Otolaryngology, Head and Neck Surgery, 20 rue Leblanc, 75015 Paris, France.
| | - C Hoffman
- Hôpital Européen Georges Pompidou, Department of Otolaryngology, Head and Neck Surgery, 20 rue Leblanc, 75015 Paris, France
| | - R Croidieu
- Hôpital Européen Georges Pompidou, Department of Otolaryngology, Head and Neck Surgery, 20 rue Leblanc, 75015 Paris, France
| | - G Vialatte de Pemille
- Hôpital Européen Georges Pompidou, Department of Otolaryngology, Head and Neck Surgery, 20 rue Leblanc, 75015 Paris, France
| | - L Crevier-Buchman
- Hôpital Européen Georges Pompidou, Department of Otolaryngology, Head and Neck Surgery, 20 rue Leblanc, 75015 Paris, France
| | - M C Monfrais-Pfauwadel
- Hôpital Européen Georges Pompidou, Department of Otolaryngology, Head and Neck Surgery, 20 rue Leblanc, 75015 Paris, France
| | - M Menard
- Hôpital Européen Georges Pompidou, Department of Otolaryngology, Head and Neck Surgery, 20 rue Leblanc, 75015 Paris, France
| | - D Brasnu
- Hôpital Européen Georges Pompidou, Department of Otolaryngology, Head and Neck Surgery, 20 rue Leblanc, 75015 Paris, France
| |
Collapse
|
22
|
Badoual C, Hans S, Merillon N, Van Ryswick C, Ravel P, Benhamouda N, Levionnois E, Nizard M, Si-Mohamed A, Besnier N, Gey A, Rotem-Yehudar R, Pere H, Tran T, Guerin CL, Chauvat A, Dransart E, Alanio C, Albert S, Barry B, Sandoval F, Quintin-Colonna F, Bruneval P, Fridman WH, Lemoine FM, Oudard S, Johannes L, Olive D, Brasnu D, Tartour E. PD-1-expressing tumor-infiltrating T cells are a favorable prognostic biomarker in HPV-associated head and neck cancer. Cancer Res 2012; 73:128-38. [PMID: 23135914 DOI: 10.1158/0008-5472.can-12-2606] [Citation(s) in RCA: 473] [Impact Index Per Article: 39.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/16/2022]
Abstract
Head and neck cancers positive for human papillomavirus (HPV) have a more favorable clinical outcome than HPV-negative cancers, but it is unknown why this is the case. We hypothesized that prognosis was affected by intrinsic features of HPV-infected tumor cells or differences in host immune response. In this study, we focused on a comparison of regulatory Foxp3(+) T cells and programmed death-1 (PD-1)(+) T cells in the microenvironment of tumors that were positive or negative for HPV, in two groups that were matched for various clinical and biologic parameters. HPV-positive head and neck cancers were more heavily infiltrated by regulatory T cells and PD-1(+) T cells and the levels of PD-1(+) cells were positively correlated with a favorable clinical outcome. In explaining this paradoxical result, we showed that these PD-1(+) T cells expressed activation markers and were functional after blockade of the PD-1-PD-L1 axis in vitro. Approximately 50% of PD-1(+) tumor-infiltrating T cells lacked Tim-3 expression and may indeed represent activated T cells. In mice, administration of a cancer vaccine increased PD-1 on T cells with concomitant tumor regression. In this setting, PD-1 blockade synergized with vaccine in eliciting antitumor efficacy. Our findings prompt a need to revisit the significance of PD-1-infiltrating T cells in cancer, where we suggest that PD-1 detection may reflect a previous immune response against tumors that might be reactivated by PD-1/PD-L1 blockade.
Collapse
|
23
|
Cros JF, Blons H, Sbidian E, Tartour E, Hans S, Brasnu D, Laurent-Puig P, Bruneval P, Badoual C. Expression and prognostic significance of directed therapy targets and mutational analysis of the EGFR pathway in malignant salivary gland tumors. J Clin Oncol 2012. [DOI: 10.1200/jco.2012.30.15_suppl.5554] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
5554 Background: Malignant salivary gland tumors are rare and pleomorphic entities (24 sub types, WHO 2005). Curative treatment relies on surgery sometimes completed by radiotherapy. Management of non-surgical, locally advanced or metastatic tumors is difficult as conventional chemotherapies are ineffective. Directed therapies may provide important benefits for these patients. The aim of this work was to assess the expression and prognostic value of directed therapy targets on salivary gland tumors and search for mutations within the key players of the EGFR pathway. Methods: Immunochemistry on formalin fixed paraffin embedded (FFPE) samples from 124 patients for c-KIT, EGFR, c-ERBB2, MUC1, phospho-mTOR, androgen/estrogens/progesterone receptors and Ki67 was performed and related to progression free interval and survival. DNA was extracted from FFPE samples and conditional for treatment mutations of EGFR/KRAS/BRAF were assessed. An additional high throughput screening for mutations of key oncogenic genes was performed. Results: EGFR was the most expressed marker, found across almost all histotypes. Expression of the other markers was heterogeneous but some potential therapy leads were suggested by high levels of C-ERBB2 and androgen receptors in salivary duct carcinomas or C-KIT over expression in myoepithetial carcinomas. Tumor grade and a high proliferation index (Ki67>20%) were associated with progression free interval and survival. None of the other marker was. No mutation was found in EGFR/KRAS/BRAF. 7% (7/104) of the tumors harbored a mutation at the codon 61 of HRAS. In epithelial and epithelial-myoépithélial carcinoma, the mutation rate reached 33%. Mutations of PI3K and p53 were the most frequently found in the broader screen. Conclusions: Several tumor subtypes expressed frequently some targets of directed therapies suggesting potential therapy leads. The EGFR/MAPK pathway seems intact suggesting a low efficacy of small kinase inhibitors such as erlotinib or gefitinib. The mutation of H-RAS, known to be important but not sufficient to trigger urothelial carcinoma, could be a key oncogenic event in tumors with a myoepithelial component.
Collapse
Affiliation(s)
| | - Helene Blons
- Hôpital Europeen Georges Pompidou, Paris, France
| | | | - Eric Tartour
- Unité d'Immunologie Biologique, Hôpital Européen Georges Pompidou, Université Paris Descartes, Paris, France
| | - Stephane Hans
- Hôpital Européen Georges Pompidou, APHP, Paris, France
| | | | | | | | | |
Collapse
|
24
|
Si-Mohamed A, Badoual C, Hans S, Péré H, Tartour E, Brasnu D. An unusual human papillomavirus type 82 detection in laryngeal squamous cell carcinoma: case report and review of literature. J Clin Virol 2012; 54:190-3. [PMID: 22480539 DOI: 10.1016/j.jcv.2012.02.024] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/12/2012] [Accepted: 02/24/2012] [Indexed: 11/26/2022]
Abstract
Squamous cell carcinoma (SCC) of the larynx is extremely rare in adolescent or younger adult and typically has an aggressive nature. The mechanism of laryngeal oncogenesis is complex and little is known about the role of human papillomaviruses (HPVs) in SCC in young age. HPV infection may occur during birth or latter by oro-genital contact. Most HPV genotypes detected were HPV 6, 11, 16, 18, 33 and 51. Herein, we report a case of invasive laryngeal SCC expressing an HPV 82 in an 18 year-old man with a history of unexplored severe acute dysphonia that started in early childhood.
Collapse
Affiliation(s)
- Ali Si-Mohamed
- Laboratoire de Virologie, Hôpital Européen Georges Pompidou (HEGP), Assistance Publique-Hôpitaux de Paris (AP-HP), Université Paris Descartes Sorbonne Paris Cité, Paris, France.
| | | | | | | | | | | |
Collapse
|
25
|
Hans S, Delas B, Gorphe P, Ménard M, Brasnu D. Transoral robotic surgery in head and neck cancer. Eur Ann Otorhinolaryngol Head Neck Dis 2012; 129:32-7. [DOI: 10.1016/j.anorl.2011.06.003] [Citation(s) in RCA: 43] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/30/2010] [Revised: 06/06/2011] [Accepted: 06/28/2011] [Indexed: 11/30/2022]
|
26
|
Hans S, Badoual C, Gorphe P, Brasnu D. Transoral robotic surgery for head and neck carcinomas. Eur Arch Otorhinolaryngol 2011; 269:1979-84. [DOI: 10.1007/s00405-011-1865-7] [Citation(s) in RCA: 31] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/05/2011] [Accepted: 11/24/2011] [Indexed: 11/28/2022]
|
27
|
Bigorgne C, Hans S, Brasnu D. [Fine needle aspiration in management of salivary gland tumors. The clinician point of view]. Ann Pathol 2011; 31:S97-9. [PMID: 22054476 DOI: 10.1016/j.annpat.2011.08.013] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/22/2011] [Accepted: 08/24/2011] [Indexed: 11/19/2022]
Affiliation(s)
- Claude Bigorgne
- Centre de pathologie et d'imagerie, 14, avenue René-Coty, 75014 Paris, France.
| | | | | |
Collapse
|
28
|
Cros J, Blons H, Bruneval P, Brasnu D, Laurent-Puig P, Badoual C. Altérations moléculaires de la voie de l’EGFR dans les tumeurs malignes des glandes salivaires. Ann Pathol 2011. [DOI: 10.1016/j.annpat.2011.09.029] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
29
|
Mirghani H, Meyer G, Hans S, Dolivet G, Périé S, Brasnu D, Guily JLS. The musculocutaneous infrahyoid flap: surgical key points. Eur Arch Otorhinolaryngol 2011; 269:1213-7. [DOI: 10.1007/s00405-011-1724-6] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/23/2011] [Accepted: 07/19/2011] [Indexed: 11/25/2022]
|
30
|
Cabane J, Brasnu D. Amyloses laryngées : le suivi à long terme en confirme la bénignité. Rev Med Interne 2011. [DOI: 10.1016/j.revmed.2011.03.078] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
31
|
Badoual C, Sandoval F, Pere H, Hans S, Gey A, Merillon N, Van Ryswick C, Quintin-Colonna F, Bruneval P, Brasnu D, Fridman WH, Tartour E. Better understanding tumor-host interaction in head and neck cancer to improve the design and development of immunotherapeutic strategies. Head Neck 2010; 32:946-58. [PMID: 20191626 DOI: 10.1002/hed.21346] [Citation(s) in RCA: 32] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022] Open
Abstract
Head and neck cancers are heavily infiltrated by immune cells, the significance of which is complex. The natural immune response against head and neck tumors, including anti-human papillomavirus (HPV) T cells, and humoral responses has been clearly documented. However, during the course of tumor progression, co-option of the immune system by tumor cells for their own advantage and increased resistance of tumor cells to immune attack also occur. Inflammation and immune subversion to support angiogenesis are key factors promoting tumor growth. Only a better understanding of this tumor-host interaction will permit a rational design of new immunotherapeutic approaches combining immunostimulation with drugs endowed with the ability to counteract immunoevasion mechanisms.
Collapse
Affiliation(s)
- Cécile Badoual
- EA 4054 Universite Paris Descartes, Ecole Nationale Vétérinaire d'Alfort, 7 Avenue du Général de Gaulle, 94704 Maisons Alfort, France
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
32
|
Abstract
The current report documents the rare clinical presentation of an imported acute and isolated glottic paracoccidioidomycosis. We discuss the diagnosis, pathogenesis, and treatment of this laryngeal disease, emphasizing the role of modern antifungal treatment, and review the relevant literature.
Collapse
Affiliation(s)
- Ollivier Laccourreye
- Department of Otorhinolaryngology-Head and Neck Surgery , Université Descartes-Paris V, HEGP, AP-HP, Paris, France
| | | | | | | |
Collapse
|
33
|
Badoual C, Hans S, Fridman WH, Brasnu D, Erdman S, Tartour E. Revisiting the Prognostic Value of Regulatory T Cells in Patients With Cancer. J Clin Oncol 2009; 27:e5-6; author reply e7. [DOI: 10.1200/jco.2009.23.0680] [Citation(s) in RCA: 31] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/01/2023] Open
Affiliation(s)
- Cecile Badoual
- Faculté de Médecine, Immunothérapie des Cancers (EA 4054), Université Paris Descartes; Ecole Nationale Vétérinaire d'Alfort; and Service d'Anatomie Pathologique, Hôpital Européen Georges-Pompidou, Assistance Publique Hôpitaux de Paris, Paris, France
| | - Stephane Hans
- Department of Otorhinolaryngology–Head and Neck Surgery, Hôpital Européen Georges-Pompidou, Assistance Publique Hôpitaux de Paris, Paris, France
| | - Wolf H. Fridman
- Service d'Immunologie Biologique, Hôpital Européen Georges-Pompidou, Assistance Publique Hôpitaux de Paris, Paris, France
| | - Daniel Brasnu
- Department of Otorhinolaryngology–Head and Neck Surgery, Hôpital Européen Georges-Pompidou, Assistance Publique Hôpitaux de Paris, Paris, France
| | - Susan Erdman
- Division of Comparative Medicine, Massachusetts Institute of Technology, Cambridge, MA
| | - Eric Tartour
- Faculté de Médecine, Immunothérapie des Cancers, Université Paris Descartes; Ecole Nationale Vétérinaire d'Alfort; and Service d'Immunologie Biologique, Hôpital Européen Georges-Pompidou, Assistance Publique Hôpitaux de Paris, Paris, France
| |
Collapse
|
34
|
Mirghani H, Francois A, Landry G, Hans S, Menard M, Brasnu D. Reprise chirurgicale du compartiment ganglionnaire central dans les cancers thyroïdiens. ACTA ACUST UNITED AC 2009; 126:37-42. [DOI: 10.1016/j.aorl.2009.02.002] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/28/2008] [Accepted: 02/13/2009] [Indexed: 12/22/2022]
|
35
|
Hans S, Bouccara D, Brasnu D. [Evolving risk factors for airway and digestive tract cancers: analysis of the data recently reported in the literature]. Ann Otolaryngol Chir Cervicofac 2009; 126:29-34. [PMID: 19233343 DOI: 10.1016/j.aorl.2008.12.003] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/01/2008] [Accepted: 12/01/2008] [Indexed: 05/27/2023]
Affiliation(s)
- S Hans
- Service d'otorhinolaryngologie et de chirurgie cervicofaciale, hôpital européen Georges-Pompidou, 20, rue Leblanc, 75908 Paris cedex 15, France.
| | | | | |
Collapse
|
36
|
Laccourreye L, Garcia D, Ménard M, Brasnu D, Laccourreye O, Holsinger FC. Horizontal supraglottic partial laryngectomy for selected squamous carcinoma of the vallecula. Head Neck 2008; 30:756-64. [DOI: 10.1002/hed.20780] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022] Open
|
37
|
Badoual C, Bouchaud G, Agueznay NEH, Mortier E, Hans S, Gey A, Fernani F, Peyrard S, -Puig PL, Bruneval P, Sastre X, Plet A, Garrigue-Antar L, Quintin-Colonna F, Fridman WH, Brasnu D, Jacques Y, Tartour E. The Soluble α Chain of Interleukin-15 Receptor: A Proinflammatory Molecule Associated with Tumor Progression in Head and Neck Cancer. Cancer Res 2008; 68:3907-14. [PMID: 18483276 DOI: 10.1158/0008-5472.can-07-6842] [Citation(s) in RCA: 67] [Impact Index Per Article: 4.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Affiliation(s)
- Cécile Badoual
- EA 4054 Université Paris Descartes, Faculté de Medecine; Ecole Nationale Vétérinaire d'Alfort, Maisons-Alfort, France
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
38
|
Abstract
OBJECTIVES We reviewed outcomes of treatment of early glottic carcinoma by transoral laser resection. METHODS We performed a retrospective study of tumor stage, type of cordectomy (European Laryngological Society), resection margins, local control, and laryngeal preservation. RESULTS Of 142 patients treated with curative intent, 79 (92% male; average age, 63 years) were retained for this study, on the basis of availability of information regarding resection margins, the absence of adjuvant radiotherapy, and followup of at least 2 years. The tumors were classified pTis (n = 21), pT1a (n = 51), or pT1b (n = 7) and were treated by cordectomy types I (23%), II (30%), III (27%), IV (6%), and V (14%). The average follow-up was 56 months (range, 24 to 150 months). The overall 5-year actuarial recurrence-free survival rate was 89%, and the 5-year actuarial disease-specific survival rate was 97.3%. There were 11 local recurrences (14%); 7 were treated by another laser resection, 1 by radiotherapy, 1 by supracricoid partial laryngectomy, and 2 by total laryngectomy. The overall rate of final local control with the laser alone was 100% for patients with initially positive margins, 95% for those with initially suspicious margins, and 94% for those with free margins. The overall rate of organ preservation was 100% for patients with positive or suspicious margins and 96% for those with free margins. Margin status (p = .39), cordectomy type (p = .67), and anterior commissure involvement (p = .16) were not statistically related to recurrence (Kaplan-Meier calculations with nonparametric univariate analysis). The recurrence rate was significantly higher for T1b tumors, however (p = .001). CONCLUSIONS Laser microresection provides high rates of local control and organ preservation for early glottic cancer. Positive or suspicious margins were not related to recurrence, nor was anterior commissure involvement. This study implies that suspicious margins can be managed with a "watch-and-wait" attitude. Re-treatment with laser, external partial laryngectomy, and radiotherapy remain therapeutic options for recurrences.
Collapse
Affiliation(s)
- Dana M Hartl
- Department of Otolaryngology-Head and Neck Surgery, Institut Gustave Roussy, 39, rue Camille Desmoulins, 94805 Villejuif, France
| | | | | | | | | |
Collapse
|
39
|
Hans S, Brasnu D. [Pain as a symptom in otolaryngology conditions]. ACTA ACUST UNITED AC 2007; 124 Suppl 1:S11-5. [PMID: 18047857 DOI: 10.1016/s0003-438x(07)80004-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
Abstract
Pain is very frequent in otolaryngology disease: headaches, facial pain, earaches, and neck pain. The search for nasal pathology with maxillary sinus, sphenoidal, or ethmoidal involvement is part of the workup for headache. Facial pain should first suggest symptomatic neuralgia through involvement of the cranial nerves - trigeminal, glossopharyngeal, superior laryngeal - even if asymptomatic neuralgia are the most frequent. Earaches should be investigated through a search for involvement of the ear at the pinna, the external acoustic conduit, and the tympanic membrane. If the ear examination is normal, pain irradiating from the masticatory apparatus, the parotid, or the oropharynx is undertaken, with a systematic search for a tumoral cause.
Collapse
Affiliation(s)
- S Hans
- Service d'ORL et de chirurgie de la face et du cou, hôpital européen Georges-Pompidou, APHP, 20, rue Leblanc, 75015 Paris, France.
| | | |
Collapse
|
40
|
Brasnu D, Poncet JL, Beauvillain C, Marandas P, Pignat JC, Barry B, Reyt E. [Carcinoma of the mobile tongue]. ACTA ACUST UNITED AC 2007; 124:244-51. [PMID: 17678867 DOI: 10.1016/j.aorl.2006.10.008] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/17/2006] [Accepted: 10/17/2006] [Indexed: 11/19/2022]
Affiliation(s)
- D Brasnu
- Service d'ORL et de chirurgie cervicofaciale, hôpital européen Georges-Pompidou, 20-40, rue Leblanc, 75015 Paris, France
| | | | | | | | | | | | | |
Collapse
|
41
|
El Houda Agueznay N, Badoual C, Hans S, Gey A, Vingert B, Peyrard S, Quintin-Colonna F, Ravel P, Bruneval P, Roncelin S, Lelongt B, Bertoglio J, Fridman WH, Brasnu D, Tartour E. Soluble interleukin-2 receptor and metalloproteinase-9 expression in head and neck cancer: prognostic value and analysis of their relationships. Clin Exp Immunol 2007; 150:114-23. [PMID: 17680822 PMCID: PMC2219282 DOI: 10.1111/j.1365-2249.2007.03464.x] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/26/2023] Open
Abstract
In a series of 84 head and neck patients, a statistically significant correlation was observed between high serum soluble interleukin (IL)-2 receptor alpha (sIL-2Ralpha) (P = 0.034) and metalloproteinase-9 (MMP-9) concentrations (P = 0.036) at diagnosis and a shorter survival of these patients. As MMP-9 has been shown to mediate cleavage of IL-2Ralpha (CD25) by preactivated T cells, we looked for a relationship between MMP-9 expression and soluble IL-2Ralpha serum concentrations in these cancer patients. We did not find any correlation between intratumoral expression of MMP-9 or serum MMP-9 concentrations and serum sIL-2Ralpha levels. These results led us to reassess the role of MMP-9 in the release of sIL-2Ralpha. Treatment of Kit225 leukaemic cells with recombinant MMP-9 slightly decreased membrane CD25 expression and was associated with an increased concentration of sIL-2Ralpha in the supernatants. However, using a selective inhibitor of MMP-9 we did not succeed in specifically inhibiting the release of sIL-2Ralpha by the Kit225 cell line or by phytohaemagglutinin (PHA)-activated peripheral blood mononuclear cells. In addition, in a preclinical mouse model, basal serum sIL-2Ralpha concentrations and sIL-2Ralpha production by activated cells were not altered in MMP-9-deficient mice compared to wild-type mice. Interestingly, a broad spectrum metalloproteinase inhibitor inhibited the release of sIL-2Ralpha by PHA-activated peripheral blood mononuclear cells, suggesting that in contrast with current views concerning the major role of MMP-9 in the cleavage of membrane IL-2Ralpha, other proteases are involved in the shedding of sIL-2Ralpha. MMP-9 and sIL-2Ralpha appear therefore as independent prognostic markers in head and neck cancers.
Collapse
Affiliation(s)
- N El Houda Agueznay
- EA 4054 Université Paris Descartes, Ecole Nationale Vétérinaire d'Alfort, Paris, France
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
42
|
Holsinger C, Bassot V, Brasnu D, Laccourreye O. Final results following exclusive chemotherapy for selected patients with squamous cell carcinoma of the laryngopharynx. J Clin Oncol 2007. [DOI: 10.1200/jco.2007.25.18_suppl.6039] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
6039 Purpose: To determine the long-term oncologic outcomes for patients with squamous cell carcinoma (SCC) of the laryngopharynx treated with exclusive chemotherapy after complete clinical response to induction chemotherapy. Materials and Methods: After platin-based induction chemotherapy, selected patients with a complete clinical and histologic response were treated exclusively with additional chemotherapy and observed closely. The rates of overall survival, disease control, and organ preservation were calculated. Results: Survival at 1- and 5-years was 94.5% and 60.2%, respectively. Main causes of death were metachronous second primaries (27) and intercurrent disease (23) than local recurrence (10), distant metastasis, (9) and nodal recurrence (4). The 1-, 3- and 5- year Kaplan-Meier local control estimates were 73.5%, 53.3%, and 50.3%, respectively. No variable was associated with local recurrence using a multivariate analysis. Salvage treatment resulted in an observed final 85.6% local control rate and varied from 96% in patients with glottic cancer to 71% in patients with tumor originating from other locations. Overall, this treatment approach was well-tolerated: 30 patients (20%) experienced grade 3 toxicity; two patients (1.4%) had grade 4 toxicity events. Overall, chemotherapy allowed for successful modulation of local therapy in 66% of patients (96/146). Conclusions: For selected patients, exclusive chemotherapy does not significantly impact survival and maintains function in a majority of patients. Most remarkable, platin-based chemotherapy permitted us to modulate and to diminish the extent of local therapy. Future work should be directed to identify markers of response and resistance to identify which patients are best suited for this approach. No significant financial relationships to disclose.
Collapse
Affiliation(s)
- C. Holsinger
- University of Texas M.D. Anderson Cancer Center, Houston, TX; Clinique St. Francois, Mainvilliers, France; Hopital Europeen Georges-Pompidou, Paris, France
| | - V. Bassot
- University of Texas M.D. Anderson Cancer Center, Houston, TX; Clinique St. Francois, Mainvilliers, France; Hopital Europeen Georges-Pompidou, Paris, France
| | - D. Brasnu
- University of Texas M.D. Anderson Cancer Center, Houston, TX; Clinique St. Francois, Mainvilliers, France; Hopital Europeen Georges-Pompidou, Paris, France
| | - O. Laccourreye
- University of Texas M.D. Anderson Cancer Center, Houston, TX; Clinique St. Francois, Mainvilliers, France; Hopital Europeen Georges-Pompidou, Paris, France
| |
Collapse
|
43
|
Affiliation(s)
- M Zanaret
- Fédération ORL, CHU de La Timone, boulevard Jean-Moulin, 13385 Marseille, France.
| | | | | | | | | |
Collapse
|
44
|
Crevier-Buchman L, Colomb I, Hans S, Vaissière J, Brasnu D. [Evolution of voice assessment and quality of life after endoscopic laser cordectomy]. Rev Laryngol Otol Rhinol (Bord) 2007; 128:315-320. [PMID: 20387377] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/29/2023]
Abstract
OBJECTIVES Endoscopic laser cordectomy is a minimally invasive surgical technique for Tis, T1 and selected T2 glottic carcinoma. The purpose of the study was to evaluate prospectively pre-operatively and 3 months after surgery i) acoustic and perceptual parameters, ii) quality of life through a self evaluation (VHI) test. METHODS A prospective longitudinal evaluation of 13 male patients, shared-out onto 3 surgical procedures (cordectomy type I, grouped type II and III, and type V). Patients were recorded before and at 1 and 3 months after surgery. The parameters recorded were; acoustic parameters (F0, Jitter, Shimmer), Maximum Phonation Time (MPT), perceptual evaluation using the GRBAS scale and the self evaluation scale with the Voice Handicap Index (VHI). RESULTS No statistics could be done because of the limited number of patients in each group. Perceptual and self evaluation data showed a favorable progression between 1 and 3 months for patients in group Type I, II and III cordectomy. Evolution of acoustic parameters is more difficult to analyze. The voice of the Cordectomy type V group remains whispery at 3 months after surgery. CONCLUSION The quality of voice is a very important criterion for the patients. During the first 3 months after laser cordectomy, the perceptual vocal function and the self evaluation improves. But for the acoustic data, 3 months is probably too short to objectively quantify an improvement especially after type V cordectomy.
Collapse
Affiliation(s)
- L Crevier-Buchman
- Hôpital Européen G. Pompidou, service d'ORL et de Chirurgie de la Face et du Cou, Université René Descartes-Paris V, Paris, France.
| | | | | | | | | |
Collapse
|
45
|
Holsinger FC, Motamed M, Garcia D, Brasnu D, Ménard M, Laccourreye O. Resection of selected invasive squamous cell carcinoma of the pyriform sinus by means of the lateral pharyngotomy approach: the partial lateral pharyngectomy. Head Neck 2006; 28:705-11. [PMID: 16786602 DOI: 10.1002/hed.20375] [Citation(s) in RCA: 29] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
Abstract
BACKGROUND Although the lateral pharyngotomy is a well-known surgical procedure, to our knowledge, no published reports have described the results achieved with a lateral pharyngectomy approach in patients with isolated and previously untreated selected invasive squamous cell carcinoma of the lateral wall of the pyriform sinus. METHODS The medical files and operative charts of 30 patients with an isolated, and previously untreated, squamous cell carcinoma of the pyriform sinus, treated for cure by lateral partial pharyngectomy and primary closure, as well as postoperative radiotherapy (n = 22), and preoperative chemotherapy (n = 8), were retrospectively studied. Sixteen tumors were classified as T1 and 14 as T2. All patients but one were followed until death. RESULTS Three patients (9%) died in the immediate postoperative period (two from medical complications and one from a surgery-related complication). Overall, 29 patients died, resulting in a 77.7%, 40%, 23.3%, and 15% 1-, 3-, 5- and 10-year Kaplan-Meier actuarial survival estimate, respectively. Only one patient had a serious postoperative complication develop. All patients were decannulated. No patients required a gastrostomy and/or completion total laryngectomy for functional reasons. Local recurrence occurred in four patients (13%). The 3-and 5-year Kaplan-Meier actuarial local control estimates were 88.5% and 79.6%, respectively. The use of a platin-based induction chemotherapy (p = .05) regimen was the only variable that was significantly statistically related to local recurrence. Overall, a 93.3% laryngeal preservation rate was achieved. CONCLUSION Partial pharyngectomy by means of the lateral pharyngotomy combined with postoperative radiation therapy is an efficient and function-sparing approach to control selected invasive squamous cell carcinomas of the lateral wall of the pyriform sinus.
Collapse
Affiliation(s)
- F Christopher Holsinger
- Department of Otorhinolaryngology-Head and Neck Surgery, Hôpital Européen Georges Pompidou, Université Paris V, 20-40, rue Leblanc, 75015 Paris, France
| | | | | | | | | | | |
Collapse
|
46
|
Badoual C, Rousseau A, Heudes D, Carnot F, Danel C, Meatchi T, Hans S, Bruneval P, Brasnu D, Laccourreye O. Evaluation of frozen section diagnosis in 721 parotid gland lesions. Histopathology 2006; 49:538-40. [PMID: 17064302 DOI: 10.1111/j.1365-2559.2006.02527.x] [Citation(s) in RCA: 15] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
47
|
Badoual C, Agueznay N, Vingert B, Hans S, Peyrard S, Bruneval P, Fridman W, Brasnu D, Tartour E. Expression du récepteur soluble à l’IL-2 et de MMP9 dans les cancers des voies aéro-digestives supérieures : valeur pronostique et analyse de leur interaction. Ann Pathol 2006. [DOI: 10.1016/s0242-6498(06)78453-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|
48
|
Hans S, Brasnu D, Chevalier D. [Organ preservation surgery in pharyngolaryngeal cancer]. Rev Prat 2006; 56:1667-74. [PMID: 17137252] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/12/2023]
Abstract
Organ preservation surgery is a reasonable name for these types of techniques because it accurately describes the postoperative outcome, which is preservation of the quintessential laryngeal functions: swallowing, respiration without a permanent stoma and speech. In response to the common use of total laryngectomy, the non-surgical approaches have often been referred to as organ preservation strategies. In many institutions, it appears that there are organ preservation strategies and then there is surgery. In our opinion there are both non surgical organ preservation strategies and surgical organ preservation strategies. The key is that in both approaches the goal is to spare the functions of the larynx. In both, the work-ups are very important to analyse 3-dimensional extent of the lesion by nasofibroscopy (laryngeal mobilities), endoscopy and radiology. Organ preservation surgical approach allowed to save the use of radiotherapy for the management of various metachronous second primary tumours.
Collapse
Affiliation(s)
- Stéphane Hans
- Service d'ORL et de chirurgie de la face et du cou, Hôpital européen Georges-Pompidou, faculté de médecine René-Descartes, Paris.
| | | | | |
Collapse
|
49
|
Crevier Buchman L, Hans S, Behm E, Tissot V, Laccourreye O, Brasnu D. [How to perform and analyze a stroboscopic examination?]. Ann Otolaryngol Chir Cervicofac 2006; 123:203-6. [PMID: 17088709 DOI: 10.1016/s0003-438x(06)76667-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/12/2023]
Affiliation(s)
- L Crevier Buchman
- Unité d'exploration voix, parole, déglutition, Service d'Otorhino-laryngologie et de Chirurgie de la face et du cou, hôpital Européen Georges Pompidou, 20 rue Leblanc, 75015 Paris
| | | | | | | | | | | |
Collapse
|
50
|
Affiliation(s)
- S Hans
- Service d'ORL et de chirurgie de la face et du cou, Hôpital Européen G. Pompidou, 20-40 rue Leblanc, 75015 Paris.
| | | | | | | | | |
Collapse
|